Data Integrity for the Pharmaceutical Industry

INVEST IN PHIZZLE TODAY!

Phizzle is a market leader in automating and digitizing scientific lab instruments used in pharma and other clean manufacturing environments. The vast majority of these instruments are not connected to a cloud based solution to harmonize or digitize their data. Phizzle is a first-mover in this market with a patented IoT solution that can remotely operate multiple types and vendors of lab instruments from the cloud. Phizzle has a recurring revenue contract with a Fortune 75 company and is FDA-compliant in its use case, which we believe is the first of its kind. The company is seeking funding to scale its operations and accelerate its current pipeline.
... Show more
This Reg CF offering is made available through StartEngine Capital, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
Phizzle

REASONS TO INVEST

Reasons Icon

Phizzle’s software platform provides large-scale pharma companies means to digitize drug production data, which is integral to ensuring the safety and efficacy of cancer drugs and other FDA-regulated prescription medications.

Reasons Icon

Since 2005, Phizzle has been dedicated to creating innovative consumer and machine data solutions. To the best of our knowledge, ours is the only SaaS-based IoT software to remotely operate multiple scientific instrument brands and systems from a single, cloud-based user interface. Our novel approach has gained FDA-clearance and proof of concept validation through contract work with Fortune 75 pharma clients.

Reasons Icon

Phizzle is poised to partner with the world’s largest pharmaceutical companies by providing a solution that integrates with existing manufacturing systems and equipment. On a global scale, the installed base of scientific lab instruments exceeds 1M units across pharma, life sciences, clean manufacturing, food production, medical environments and office buildings. The market for these devices is growing, with particle counters, for example, projected at a 9% CAGR through 2027.*


*Information from Credible Markets, "Global Market Industry Value, Size, Share, Growth, Trends and Forecast, 2016-2027" for Analytical Balances, PH Meters, Particle Counters.


A Digital Solution For Unlocking Valuable Scientific Data in a Highly Regulated Environment

Phizzle’s cloud-native, microservices-based software platform offers world-leading pharmaceutical enterprises a solution to upgrade existing equipment, so they can produce life-saving medications with improved safety, compliance, and cost-efficiency.


Using our FDA-compliant system, drug companies are able to automate operations and enable optimized workflows, while also ensuring data integrity and minimizing the potential for human error. We believe ours is the first scalable platform of its kind targeting an entire ecosystem of devices waiting to be digitized across a landscape of laboratories worldwide.

The Problem & Our Solution


Modernizing Pharmaceutical Manufacturing Processes for Safety & Data Integrity

While the pharmaceutical industry is known for innovation, very little has changed in the world of drug production data. In order to be compliant with regulations and safety standards, laboratories rely on a variety of scientific instruments – including particle counters, balances, pH meters, and other equipment spanning decades of different makes and models – to manufacture pharmaceuticals. 



For most companies, no central platform has previously existed to harmonize operations. As such, lab technicians still conduct a majority of testing manually, which results in a wide margin for human error. When mistakes happen, entire batches of product must be discarded and the recall process can total hundreds of millions of dollars, such as Pfizer’s infamous Bextra recall.


In order to avoid these kinds of costly errors, as well as ensure a safer and more streamlined production process, Phizzle has developed the digital architecture needed to capture this data holistically. Using our EDGMaker software platform, technicians are provided with all of the information from individual instruments on one digitized dashboard, which can be accessed and operated remotely.


*Testimonials may not be representative of the experience of other customers and is not a guarantee of future performance or success.

(source)

*Testimonials may not be representative of the experience of other customers and is not a guarantee of future performance or success.

(source)



Phizzle has contracted with universities across the country to bring pharmaceutical device technology to the broader public - specifically air quality testing after the initial outbreak of COVID-19.


Scientific lab instruments are some of the best tools in the world for diagnosis and measurement. Phizzle works with institutions like the University of Arizona to use them for quantifying and improving air quality on campuses.


For example, our particle counter testing at University of Arizona showed consistent and predictable "bad air" spikes during highly-trafficked hours at the largest student center. Data also indicated consistently bad air in the most trafficked reception area because the floor trash cans were placed next to the front desk where students waited. They were rarely emptied throughout the day and an easy change to make for the university.


Arizona changed the location of their trash and shifted foot traffic during COVID-19 to improve air quality and help keep students safe. Phizzle provided the device know-how and platform to implement immediate and actionable changes during this process.

The Market & Our Traction


Achieving Major Milestones on Our Way to Serving the Global Pharma Industry

For the past few years, Phizzle has been making significant strides to establish the EDGMaker software stack as an industry-innovating technology. Our platform is unique to the market, in that it has already secured FDA approval for our use case and designation for virtualizing scientific lab instruments. With this clearance in place, the company has gained a competitive edge and accomplished proof of concept by partnering with its first Fortune 75 pharmaceutical manufacturer.



Through our work we’ve been able to successfully digitize more than 40K samples from facilities producing one of the world’s best-selling cancer treatment drugs, and are on pace to reach 100K by the end of this year. 


(source)


We’ve also effectively doubled our total addressable market by adding three new scientific lab instruments to our portfolio, and been recognized by Forbes.comCRN, and the IoT Community.


Why Invest


Our Vision is Validated through Fortune Company Partnerships & Greenlit by the FDA

Although Phizzle started as a small technology company, achieving FDA-compliant status and signing with a Fortune 75 pharma customer are a testament to the technology we've developed and our in-market advantage



As we surpass our goal of 100K digitized samples and continue to grow our pipeline of potential customers to include other large-scale pharmaceutical customers, support from funding will allow us to expand our resources and serve the industry on a global scale. Help us continue on our trajectory to success by investing today!



Code View

ABOUT

HEADQUARTERS
943 Howard Street
San Francisco, CA 94103
VALUATION
$78.29M

Phizzle is a market leader in automating and digitizing scientific lab instruments used in pharma and other clean manufacturing environments. The vast majority of these instruments are not connected to a cloud based solution to harmonize or digitize their data. Phizzle is a first-mover in this market with a patented IoT solution that can remotely operate multiple types and vendors of lab instruments from the cloud. Phizzle has a recurring revenue contract with a Fortune 75 company and is FDA-compliant in its use case, which we believe is the first of its kind. The company is seeking funding to scale its operations and accelerate its current pipeline.

TEAM

Ben Davis III
Ben Davis III
Chief Executive Officer, Board Member, Director

Ben Davis co-founded Phizzle in 2005 and has led the company to its current market position as the leader in automating and digitizing scientific lab instruments used in pharma and other clean manufacturing environments, raising $25 million in VC funding. Ben is a serial entrepreneur and leading voice in the Pharma IoT space. In 2003, Ben co-founded Pixiem, an early developer and publisher of mobile video games, where some of his customers included ESPN and Wimbledon. Pixiem was acquired by WinWin Gaming in 2005. Ben serves on the IoT Community board of advisors and the IoT Community’s Converged Edge Center of Excellence. Ben is also a board member at Elon University, School of Communications; member of the Alliance of Chief Executives; and member of the board of directors of Boys Hope Girls Hope. Formerly a professional basketball player in Europe, he currently resides in San Francisco. Ben is a graduate of Walsh University with a BA in Business

Stephen Peary

Stephen Peary

Chief Financial Officer and General Counsel

Stephen Peary is a seasoned public company executive having closed in excess of $4 billion in financings. He has held direct reporting responsibility for a $300 million revenue department, engineered financial turnarounds for public and non-public companies, and led multiple functions including M&A, HR, Accounting, Finance and Legal. Stephen has authored numerous SEC registration and reporting documents. He serves as a member of the board of directors and chair of the audit committee for NCIRE - Veterans Health Research Institute (a joint venture between UCSF and SFVA). He is also a board member and chair of the governance committee of Vantage West Credit Union. Stephen holds a B.A. (Economics) from the University of Illinois ; a J.D. from Georgetown University Law Center and an LLM (Taxation) from Boston University. 

Ryan Brady

Ryan Brady

Chief Technical Officer

Ryan Brady serves as Phizzle’s technical lead and specializes in building systems that make IoT work for real-time engagement. Ryan’s engineering experience and technical vision helped transition the company into pharmaceutical manufacturing before he became CTO. Prior to Phizzle, Ryan served as a trial consultant working closely with experts in the medical, transportation, oil & gas, technology and structural engineering industries. Using many of the same tools he created to automate the visualization of large amounts of data in real-time, Ryan brought his expertise to the SaaS industry and helped transition Phizzle’s technology into an IoT manufacturing solution.

Ron Ricci

Ron Ricci

Chair of Board

Ron Ricci has spent his entire career helping CEOs and companies tell their stories. He has worked with CEOs like Michael Dell, Eric Schmidt and Carol Bartz; and discussed leadership with Richard Branson and Jack Welch. He spent 20 years at Cisco, including a decade as a direct report to CEO John Chambers. Ron has authored Momentum, published by Harvard Business School Publishing, and The Collaboration Imperative, which shared the best practices Cisco used to work better together. He is currently the founder and CEO of The Transparency Imperative, the only software platform to measure how engaged leaders and managers are with their employees and culture."

Mark Krentzman

Mark Krentzman

Director

Mr. Krentzman is a well-known investor, owner, entrepreneur and turnaround manager, having been involved in various ownership and management capacities with several companies during the past thirty years. He is an investor and Board member in Phizzle a West Coast based software company that is the leader in Edge Computing and IoT software. He has served as Executive Chairman of Jones and Veining an international shoe component manufacturer with operations in the USA, China, Vietnam, Thailand and Indonesia. He has helped raise financing for BioVentures Investors a leading biomedical investment fund in drugs and medical instrumentation. He has consulted on business strategy and strategic marketing for companies in the internet, defense, biotechnology and technology industries and served in a senior management capacity for a facilities-based provider of telecommunications products and services. 

Mr. Krentzman has a strong track record as an entrepreneur in working with software, medical technology, internet and telecommunications businesses, both in connection with fundraising and identifying significant opportunities for investment and growth in these fields, as well as helping in the turnaround of under-performing companies and creating significant value for shareholders.

Mr. Krentzman received a MBA from the Harvard University Graduate School of Business with an emphasis on manufacturing and marketing, and a BS in Finance, Magna Cum Laude, from Northeastern University School of Business. He currently serves as an Emeritus Corporator of Northeastern University and served as Co-Chair of his HBS Alumni Class. He also serves as a Trustee Emeritus of the Norman Rockwell Museum in Stockbridge, MA. Mr. Krentzman Is an Owner of Jones & Vining.

Edwin Lau

Edwin Lau

Director and Acting President

Ed Lau is the co-founder of Audible (NASDQ: AMZN) and New Moon Systems (NASDQ: ORCL). He has spent 15+ years in Venture Capital and 25+ years operating within technology startups. As an investor, Ed is hands-on entrepreneur, rolling up his sleeves in operational roles in TuneIn, Inc. and Phizzle, Inc. Ed is co-author of 11 issued patents. He holds a Ph.D. and M.S. degrees in Computer Science from the University of California, Berkeley, and a A.B. in Computer Science and Mathematics from New York University.

Michael Patrick

Michael Patrick

Chief Innovation Officer

Michael started with Phizzle in 2008 and brings decades of experience to the team in the design, development, and integration of high availability real-time systems. Prior to Phizzle, Michael developed mission/life-critical software in commercial, military, and space-based platforms for companies such as Boeing and BAE Systems. Michael's broad and extensive expertise in implementing high performance solutions has been key to Phizzle's software and forms the core engine of Phizzle's IoT solution. In his spare time Michael is a mentor for a FIRST robotics team where he brings his passion for engineering, science and robotics to high school students. Michael received a BS in Electrical and Computer Engineering from SUNY Buffalo in 1983.

Lena Wu

Lena Wu

Industry Advisor

Lena Wu, Ph.D. is an Independent Director for Matterworks, Inc, developing tools for biomanufacturing. She is the former co-founder and CEO of Intabio, Inc that developed analytical systems for biomanufacturing and was acquired by SCIEX. She was previously the CEO and co-founder of Rogne Biosciences, a biotherapeutic company. Lena has 25+ years of corporate development experience in early stage life science companies. Lena received her Ph.D. in Molecular Pharmacology from Stanford School of Medicine.

Cecilie Carter

Cecilie Carter

Senior Director

Cecilie is an experienced Emmy-nominated Marketing Professional with a demonstrated history of quality work in the Tech and Creative spaces. At Phizzle, Cecilie manages GTM Operations which includes; marketing campaigns, social media postings, company branding, and other strategic marketing activities. Historically she has displayed repeated success in maintaining positive relationships with existing and new clients and ensuring customer satisfaction. Her ability to combine industry knowledge with campaign development and media expertise has resulted in elevated brand profiles for Phizzle. 

William Valtos

William Valtos

Director

William Valtos Jr. has been building and advising companies for over 30 years in C-suite/Board roles as an institutional investor, adviser, and strategist. Since March 2020, Billy has shifted his focus to digital transformation and emerging technologies which can help enterprise companies sustain growth and innovation as business models and customer behaviors change. 

Professional Expertise: A former investment banking CEO, Mr. Valtos has a deep network and extensive deal experience in Silicon Valley, Southeast Asia, and Japan. He has managed a number of businesses in different geographies and has cross-border experience in mergers and acquisition, capital markets strategy, venture capital, private equity, and strategic finance. Mr. Valtos co-founded and led a Top-Quartile venture capital firm, tracked. He is well-regarded for building strong corporate cultures and committed teams, organizational change, and corporate governance.

James Whims

James Whims

Director

Jim serves as Director and is a Partner at Alsop-Louie Partners. For the last decade, Jim was a partner at Techfund Capital in the U.S. and Europe, where he invested in companies like 3DFX and Portal Player. Jim was a co-founder of Worlds of Wonder and a key executive at Software Toolworks and Sony Computer Entertainment. In 1996, Adweek/Brandweek recognized him as the Marketing Executive of the Year for driving revenues from zero to $1B in one year at Sony, where Jim managed the launch of the Playstation in North America. Jim also serves on the Board of Directors at THQ and Synaptics. He received his MBA in Finance from the University of Arizona and a BS from Northwestern University

Kari Baker

Kari Baker

VP Customer Success & Operations

Kari has built Phizzle’s Support and Customer Success teams from the ground up for IoT in the pharmaceutical manufacturing industry. Her commitment to excellence, ability to solve complex problems, and knack for building high-performing teams has helped Phizzle create trusted relationships with Pharma customers, partners, and stakeholders. Kari is Phizzle’s official Voice of the Customer.

Thomas Toy

Thomas Toy

Director

Thomas Toy serves as Director and is a Managing Director of Startup Capital Ventures Fund II and a Limited Partner of Fund I. Tom has been Managing Director of PacRim Venture Partners, a Menlo Park-based venture capital firm specializing in diversified information technology, technology and clean technology companies. Tom presently serves on the board of directors of portfolio company HealthCrowd.

TERMS

Phizzle
Overview
PRICE PER SHARE
$0.40
DEADLINE
Feb 14, 2023
VALUATION
$78.29M
AMOUNT RAISED
$140,756.81
Breakdown
MIN INVESTMENT
$200.00
MAX INVESTMENT
$5,000,000.00
MIN NUMBER OF SHARES OFFERED
25,000
OFFERING TYPE
Equity
ASSET TYPE
COMMON
SHARES OFFERED
Common Stock
MAX NUMBER OF SHARES OFFERED
12,500,000

Maximum Number of Shares Offered subject to adjustment for bonus shares


Company

:

Phizzle, Inc

Corporate Address

:

943 Howard Street, San Francisco, CA 94103

Offering Minimum

:

$10,000.00

Offering Maximum

:

$5,000,000.00

Minimum Investment Amount

(per investor)

:

$200.00











Terms


Offering Type

:

Equity

Security Name

:

Common Stock

Minimum Number of Shares Offered

:

25,000

Maximum Number of Shares Offered

:

12,500,000

Price per Share

:

$0.40

Pre-Money Valuation

:

$78,293,266.40











Voting Rights of Securities Sold in this Offering

Voting Proxy. Each Subscriber shall appoint the Chief Executive Officer of the Company (the “CEO”), Chairman of the Board of Directors, or his or her successor, as the Subscriber’s true and lawful proxy and attorney, with the power to act alone and with full power of substitution, to, consistent with this instrument and on behalf of the Subscriber, (i) vote all Securities, (ii) give and receive notices and communications, (iii) execute any instrument or document that the CEO determines is necessary or appropriate in the exercise of its authority under this instrument, and (iv) take all actions necessary or appropriate in the judgment of the CEO for the accomplishment of the foregoing. The proxy and power granted by the Subscriber pursuant to this Section are coupled with an interest. Such proxy and power will be irrevocable. The proxy and power, so long as the Subscriber is an individual, will survive the death, incompetency and disability of the Subscriber and, so long as the Subscriber is an entity, will survive the merger or reorganization of the Subscriber or any other entity holding the Securities. However, the Proxy will terminate upon the closing of a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933 covering the offer and sale of Common Stock or the effectiveness of a registration statement under the Securities Exchange Act of 1934 covering the Common Stock.

*Maximum number of shares offered subject to adjustment for bonus shares. See Bonus info below.

Investment Incentives and Bonuses*


Time Based Bonus
Friends and Family Early Birds

Invest $200 within the first 48 hours and receive 20% bonus shares.

Super Early Bird Bonus

Invest $200 within the first week and receive 15% bonus shares.

Early Bird Bonus

Invest $200 within the first month and receive 10% bonus shares.

 

Amount-Based:

$500+ | Tier 1

Invest $500+ and receive 5% bonus shares.

$1,000+ | Tier 2

Invest $1,000+ and receive 10% bonus shares.

 

$5,000+ | Tier 3

Invest $5,000+ and receive 15% bonus shares.

 

$10,000+ | Tier 4

Invest $10,000+ and receive 20% bonus shares.

 

$20,000+ | Tier 5

Invest $20,000+ and receive 20% bonus shares and an invite to a webinar with the CEO

 

Loyalty Bonus:
As you are an existing Stockholder / Noteholder/ TTW Email recipient in Phizzle, receive 10% Additional Bonus Shares.

*In order to receive perks from an investment, one must submit a single investment in the same offering that meets the minimum perk requirement. Bonus shares from perks will not be granted if an investor submits multiple investments that, when combined, meet the perk requirement. All perks occur when the offering is completed.



The 10% StartEngine Owners' Bonus

Phizzle, Inc will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Common Stock at $0.40/ share, you will receive 110 shares of Common Stock, meaning you'll own 110 shares for $40. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investor's eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.

Investors will receive the highest single bonus they are eligible for among the bonuses based on the amount invested and the time of offering elapsed (if any). Eligible investors will also receive the Owner’s Bonus and an audience-based bonus of 10% for Phizzle Existing Stockholders/Noteholders/TTW Email Recipients, in addition to the aforementioned bonus.

Irregular Use of Proceeds

The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Vendor payments. Salary payments made to one’s self, a friend or relative. Any expense labeled “Travel and Entertainment”.

PRESS

Article Image
Forbes

Pharmaceutical Manufacturing Just Got An Automation Boost From IoT

Article Image
Facility Executive

Collaboration To Measure Air Quality

Article Image
EDGEIR.com

How Phizzle is helping pharma companies wrangle data from edge devices—and a big ROI

Article Image
The Channel CO

The 10 Hottest IoT Startups Of 2020 (So Far)

Article Image
Enterprise Viewpoint

How Digitization and Automation is Meeting the Pharmaceutical Industry’s Need for Greater Manufacturing Capacity










ALL UPDATES

12.07.22

StartEngine Exclusive: Investor Roundtable

Watch this valuable investor roundtable ONLY ON StartEngine. Hear successful industry leaders, Ron Ricci, Lena WuEd Lau and Ira Shapiro discuss WHY they became Phizzle investors



You can be an investor too!! Hurry before the early bird special ends.

INVEST NOW

12.05.22

MAJOR industry leaders believe in Phizzle

11.30.22

StartEngine Sneak Peak

For StartEngine Only - Here's what's coming next on our expanding roadmap.

Invest in Phizzle Now

11.28.22

Phizzle Has Raised MORE THAN $100K Within 10 Days!!

We are SUPER excited to announce that Phizzle has reached more than $100K in investments within the first ten days of our StartEngine campaign... AND last week, we received a $25,000 INVESTMENT! 

We are FDA-compliant with an F75 customer, +1mm revenue and a sales pipeline. If you are considering investing in Phizzle, we urge you to take advantage of our Early Bird Special.

Make sure to follow our page and stay up to date with our upcoming and exciting news!  INVEST NOW

-> INVEST NOW<-

11.23.22

Credible Industry Leaders with Fantastic Track Records, Speak on WHY they believe in Phizzle!

Ed Lau, Ron Ricci and Lena Wu, credible industry leaders AND Investors, speak on WHY they believe in Phizzle

Invest NOW! You can still take advantage of the Early Bird Special!

https://www.startengine.com/offering/phizzle 


11.21.22

Phizzle Reaches More Than 100 Investors in Less Than 7 Days!!

We are proud to reach 100+ investors in less than 7 days! You too can invest in Phizzle! You still have time to take advantage of the early bird special. Go to https://www.startengine.com/offering/phizzle. Act fast and join us in making history!

phizzle.com


11.17.22

Phizzle's Self Service Demo

Do you want to see what our software looks like?  Take a walk through Phizzle's Self Service Demo. You will have the opportunity to experience the functionality and power of our technology when deployed at Pharma’s  IoTEdge.

- > phizzle.com/self-service-d


11.15.22

Phizzle's Education Update

Phizzle's expertise with scientific lab instruments isn't just a strong business model — it’s unearthed critical health data. Our Digital Air Guide helped educate the market in 2020 on why indoor air quality was (1) directly linked to respiratory health and (2) traceable using the proper tools and system. 


Read more about the dangers of PM2.5 and the steps you can take to protect your office or home this year.



11.15.22

Phizzle Goes Live with StartEngine Investment Community; IoT Software Leader Targets Growth Capital










10%
Early Bird Bonus

Invest $200 within the first month and receive 10% bonus shares.

06
DAYS
12
HOURS
10
MINS
58
SECS
Owners bonus
Stack Owner's Bonus & Rewards!

Members get an extra 10% shares in addition to rewards below!

REWARDS

Multiple investments in an offering cannot be combined to qualify for a larger campaign perk. Get rewarded for investing more into Phizzle.

$200.00

StartEngine Owner’s Bonus

This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.

$200.00

Early Bird Bonus

Invest $200 within the first month and receive 10% bonus shares.

$500.00

$500+ | Tier 1

Invest $500+ and receive 5% bonus shares.

$1,000.00

$1,000+ | Tier 2

Invest $1,000+ and receive 10% bonus shares.

$5,000.00

$5,000+ | Tier 3

Invest $5,000+ and receive 15% bonus shares.

$10,000.00

$10,000+ | Tier 4

Invest $10,000+ and receive 20% bonus shares.

$20,000.00

$20,000+ | Tier 5

Invest $20,000+ and receive 20% bonus shares and an invite to a webinar with the CEO

JOIN THE DISCUSSION













0/2500

HOW INVESTING WORKS

Cancel anytime before 48 hours before a rolling close or the offering end date.

WHY STARTENGINE?

REWARDSWe want you to succeed and get the most out of your money by offering rewards and memberships!
SECUREYour info is your info. We take pride in keeping it that way!
DIVERSE INVESTMENTSInvest in over 200 start-ups and collectibles!

With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.

With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.

At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.

Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.

StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.

For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.

For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.

Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.

Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.

Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.

@ 2022 All Rights Reserved

Apple Store Logo

Get To Know Us

Our Team

Careers

Important Message

IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON STARTENGINE ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.


www.StartEngine.com is a website owned and operated by StartEngine Crowdfunding, Inc. (“StartEngine”), which is neither a registered broker-dealer, investment advisor nor funding portal.


Unless indicated otherwise with respect to a particular issuer, all securities-related activity is conducted by regulated affiliates of StartEngine: StartEngine Capital, LLC, a funding portal registered here with the US Securities and Exchange Commission (SEC) and here as a member of the Financial Industry Regulatory Authority (FINRA), or StartEngine Primary, LLC, a broker-dealer registered with the SEC and FINRA/SIPC . You can review the background of our broker-dealer and our investment professionals on FINRA’s BrokerCheck here. StartEngine Secondary is an alternative trading system regulated by the SEC and operated by StartEngine Primary, LLC, a broker dealer registered with the SEC and FINRA. StartEngine Primary, LLC is a member of SIPC and explanatory brochures are available upon request by contacting SIPC at (202) 371-8300.


Investment opportunities posted and accessible through the site are of three types:


1) Regulation A offerings (JOBS Act Title IV; known as Regulation A+), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Primary, LLC (unless otherwise indicated). 2) Regulation D offerings (Rule 506(c)), which are offered only to accredited investors. These offerings are made through StartEngine Primary, LLC. 3) Regulation Crowdfunding offerings (JOBS Act Title III), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Capital, LLC. Some of these offerings are open to the general public, however there are important differences and risks.


Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. StartEngine and its affiliates do not provide any investment advice or recommendation and do not provide any legal or tax advice with respect to any securities. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. StartEngine does not verify the adequacy, accuracy or completeness of any information. Neither StartEngine nor any of its officers, directors, agents and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site. See additional general disclosures here.


By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.


Canadian Investors Investment opportunities posted and accessible through the site will not be offered to Canadian resident investors. Potential investors are strongly advised to consult their legal, tax and financial advisors before investing. The securities offered on this site are not offered in jurisdictions where public solicitation for offerings is not permitted; it is solely your responsibility to comply with the laws and regulations of your country of residence.


California Investors Only – Do Not Sell My Personal Information (800-317-2200). StartEngine does not sell personal information. For all customer inquiries, please write to contact@startengine.com.


StartEngine’s Reg A+ offering is made available through StartEngine Crowdfunding, Inc. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. For more information about this offering, please view StartEngine’s offering circular and risk associated with this offering.